| | Measurement | Control () | Telmisartan () | Control (mean/sd) | Telmisartan (mean/sd) | Difference (, 95% CI) | value |
| | CBF, mL/min/100 g | | | | | | | | Global | 6 | 9 | 41.4 (10.0) | 46.3 (10.1) | −1.2 (−16.9, 4.6) | 0.24 | | Ipsilateral hemispheric | 6 | 9 | 38.9 (10.4) | 45.4 (10.6) | −1.5 (−17.8, 3.1) | 0.15 | | ACA | 6 | 9 | 48.6 (16.2) | 50.4 (10.1) | −0.3 (−16.5, 12.0) | 0.74 | | MCA | 6 | 9 | 40.2 (11.9) | 48.7 (10.7) | −1.4 (−17.2, 3.7) | 0.18 | | PCA | 6 | 9 | 39.9 (13.1) | 53.0 (27.2) | −1.5 (−37.8, 6.4) | 0.15 | | CBF, mL/min/100 g | | | | | | | | Contralateral hemispheric | 6 | 9 | 42.7 (9.4) | 47.2 (10.2) | −1.1 (−17.4, 5.9) | 0.30 | | ACA | 6 | 9 | 56.0 (21.4) | 55.5 (11.0) | 0.03 (−18.6, 19.1) | 0.99 | | MCA | 6 | 9 | 46.5 (10.2) | 49.5 (12.7) | −0.7 (−16.9, 8.8) | 0.51 | | PCA | 6 | 9 | 41.8 (12.6) | 51.2 (15.3) | −1.3 (27.0, 6.7) | 0.21 | | Lesion area, pixels | 6 | 9 | 1171 (690) | 1114 (905) | −1 (−53, 22) | 0.38 | | Oligaemia | 6 | 9 | 315 (184) | 273 (183) | 0 (−141, 193) | 0.74 | | Penumbra | 6 | 9 | 207 (191) | 154 (183) | 2 (−21, 146) | 0.13 | | Core | 6 | 9 | 206 (290) | 139 (213) | 1 (−68, 171) | 0.36 | | TCD ipsilateral | | | | | | | | Systolic CBFv (cm/s) | 4 | 6 | 61.0 (13.0) | 80.5 (24.0) | −0.8 (−33.5, 16.5) | 0.45 | | CPP | 4 | 6 | 61.0 (10.8) | 56.6 (13.2) | 0.5 (−16.6, 26.3) | 0.61 | | ZFP | 4 | 6 | 56.8 (16.5) | 48.5 (9.7) | 0.9 (−11.8, 26.2) | 0.40 | | Augmentation index | 7 | 9 | 29.3 (10.3) | 28.4 (12.4) | 1.1 (−6.0, 17.7) | 0.31 | | Buckberg index | 7 | 9 | 162.4 (38.3) | 161.7 (35.9) | −2.1 (−49.3, 0.8) | 0.06 |
|
|
